Table of Contents
1 Stem Cell Research and Development - Executive Summary
1.1 High Unmet Needs Associated with Chronic Diseases Boosts Stem Cell Research and Development
1.2 High Market Potential for Stem Cell Therapies has resulted in Establishing Strategic Partnerships between Large Pharmaceutical Companies and Stem Cell Research Based Companies
1.3 Promising Pipeline in Phase II and Phase III has Increased the Hopes of Commercialization of Stem Cell Therapies
1.4 Supportive Regulatory Environment Coupled with Increase in Investments have Bolstered the Growth of Stem Cell Research
1.5 Key Geographies are Attracting Investments by Promoting Stem Cell Tourism
2 Table Of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 GBI Research Report Guidance
4 Market Overview
4.1 Stem Cell Research – An Introduction
4.2 Types of Stem Cell Research
4.3 Unmet Needs
4.4 Applications of Stem Cell Research
5 Market Characterization
5.1 Stem Cell Market – An Introduction
5.2 Market Sizing
5.3 Therapy cost
5.4 Technology Adoption Framework
5.5 Types of Business Models
5.6 Market Drivers
5.6.1 Supporting Political Environment on Embryonic Stem Cell Research will Advance the Stem Cell Industry to Prosper in the United States
5.6.2 Limited Availability of Treatments to Treat Certain Disease Conditions Increases Market Opportunity for Stem Cell Research
5.7 Market Barriers & Challenges
5.7.1 Stem Cell Research and Development is an expensive process which requires considerable funding to operate
5.7.2 Availability of Adequate Reimbursements are Unclear and leads to a conundrum
5.7.3 Ethical, legal and social issues persists and acts as a challenge
5.7.4 Identifying, recruiting and retaining the best scientific talents is an intractable process for stem cell research based companies
5.8 Stem Cell Research and Development - Market Trends
5.8.1 Booming Stem Cell Tourism is a Potential Opportunity for Countries to Attract Investments.
5.8.2 ASLAP Analysis of Stem Cell Tourism
5.8.2.1 The Present Situation
5.8.2.2 Actors
5.8.2.3 Process
5.8.2.4 Learning
5.8.2.5 Actions
5.8.2.6 Performance
5.8.3 Federal Funding Support Improves the Stem Cell Research Environment
5.8.4 Increasing Entry of Pharmaceutical Companies Boosts Stem Cell Research & Development
5.8.5 PESTLE Analysis
5.8.5.1 Political Environnent
5.8.5.2 Economic Environnent
5.8.5.3 Society
5.8.5.4 Technology
5.8.5.5 Legislation
5.8.5.6 Environment
5.8.6 SWOT Analysis of Stem Cell Research & Development
5.8.6.1 Strengths
5.8.6.2 Weakness
5.8.6.3 Opportunities
5.8.6.4 Threats
5.9 Industry Analysis
5.9.1.1 Industry Rivalry
5.9.1.2 Threat of New Entrant
5.9.1.3 Threat of Substitutes
5.9.1.4 Supplier Power
5.9.1.5 Buyer Power
6 Stem Cell Research and Development - Pipeline Analysis
6.1 Pipeline by Various Phases
6.2 Phase III Pipeline Analysis
6.3 Phase II Pipeline Analysis
6.4 Preclinical and Phase 1 Pipeline
7 Stem Cell Research and Development - Investment Trends
7.1 Investor’s Perspective on Stem Cell Research
7.1.1.1 Status of Research
7.1.1.2 Regulatory Position
7.1.1.3 Clinical Development
7.1.1.4 Commercial Models
7.1.1.5 Patent Policy
7.2 NIH spending in Stem Cell Research and Development is Increasing and is Supportive
7.2.1 NIH Spending by Stem Cell Research Type
7.2.2 High Budget Projects Funded by NIH
7.3 States Funding on Stem Cell Research in the US is in Reconsideration.
7.4 R&D Spending by Stem Cell Research Companies
8 Stem Cell Research and Development - Geographical Trends
8.1 Stem Cell Companies by Geographic Regions
8.2 The United States
8.3 United Kingdom
8.4 China
8.5 Netherlands
8.6 Singapore
8.7 South Korea
8.8 Japan
8.9 India
8.10 Sweden
8.11 Denmark
8.12 France
8.13 Germany
8.14 Israel
8.15 Australia
8.16 Canada
8.17 Czech Republic
9 Stem Cell Research and Development - Mergers and Acquisitions
10 Stem Cell Research and Development - Competitive Structure
10.1 Stem Cell Companies by Therapy Areas
10.2 Stem Cell Companies by Stem Cell Types
11 Stem Cell Research and Development - Company Profiles
11.1 Aastrom Biosciences
11.2 Osiris Therapeutics
11.3 Bioheart
11.4 Aldagen
11.5 Mesoblast
11.6 Geron
11.7 Advanced Cell Technology
11.8 Cytori Therapeutics
11.9 Pluristem Therapeutics
11.10 Medistem
11.11 Neostem
12 Stem Cell Research and Development - Conclusion
13 Appendix
13.1 Market Definitions
13.2 Key Support Data
13.3 Abbreviations
13.4 Methodology
13.4.1 Coverage
13.4.2 Secondary Research
13.4.3 Primary Research
13.4.4 Expert Panels
13.5 Contact Us
13.6 Disclaimer